The influence of leukocytospermia on the outcomes of assisted reproductive technology

Detalhes bibliográficos
Autor(a) principal: Cavagna, Mario
Data de Publicação: 2012
Outros Autores: Oliveira, Joao Batista A. [UNESP], Petersen, Claudia G. [UNESP], Mauri, Ana L., Silva, Liliane F. I. [UNESP], Massaro, Fabiana C., Baruffi, Ricardo L. R., Franco, Jose G. [UNESP]
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNESP
Texto Completo: http://dx.doi.org/10.1186/1477-7827-10-44
http://hdl.handle.net/11449/12275
Resumo: Background: It is not well established whether the increased number of leukocytes in the seminal fluid impairs the outcomes of assisted reproductive technology (ART). This investigation analysed the outcomes of the intracytoplasmic sperm injection (ICSI) and intracytoplasmic morphologically selected sperm injection (IMSI) cycles in couples in which the male partner exhibited leukocytospermia.Methods: A total of 100 cycles in 100 couples were included in this study. For the ICSI or IMSI procedures, the patients were divided into two groups according to the presence or absence of leukocytospermia and then matched by (female) age:- ICSI: Group I (n = 25): Leukocytospermia - semen samples with a leukocyte count of greater than or equal to 1 x 10(6)/mL; and Group II (n = 25): Non-leukocytospermia - semen samples with a leukocyte count < 1 x 10(6)/mL.- IMSI: Group I (n = 25): Leukocytospermia; and Group II (n = 25): Non-leukocytospermia.The endpoints included the rates of fertilisation, implantation, clinical pregnancy, miscarriage, ongoing pregnancy and live birth. Student's t-tests, Mann-Whitney tests and Chi-square tests were performed, and P < 0.05 was considered significant.Results: The data from the ICSI groups showed that leukocytospermia did not have a negative influence on the rates of fertilisation (Group I: 57.9+/-30.2%, Group II: 61.9+/-27.7%; P = 0.74), implantation (Group I: 12.3%; Group II: 13.5%; P = 0.93), clinical pregnancy (Group I: 24%; Group II: 24%; P = 1.0), miscarriage ( Group I: 0, Group II: 0), ongoing pregnancy (Group I: 24%; Group II: 24%; P = 1.0), or live births (Group I: 24%; Group II: 24%; P = 1.0). Similarly, the data from the IMSI groups also showed that the leukocytospermia did not have a negative influence on the rates of fertilisation (Group I: 67.6+/-24.6%, Group II: 59.5+/-28.1%; P = 0.36), implantation (Group I: 17.5%; Group II: 16.7%; P = 0.90), clinical pregnancy (Group I: 28%; Group II: 24%; P = 1.0), miscarriage (Group I: 14.3%; Group II: 0; P = 0.33), ongoing pregnancy (Group I: 24%; Group II: 24%; P = 1.0), or live births (Group I: 24%, 6/25; Group II: 24%, 6/25; P = 1.0).Conclusions: The results indicate that the leukocytospermia may not have a negative effect on the outcomes of ICSI or IMSI cycles. Nevertheless, it seems that it is necessary to more precisely determine the effects, if any, of seminal leukocytes on fertilisation and implantation processes. Such efforts will help to establish a more reliable leukocyte threshold, which could eventually demonstrate whether there is a negative influence on the ART procedures.
id UNSP_21e374b632977f5a0bc7934bd4f2cfb0
oai_identifier_str oai:repositorio.unesp.br:11449/12275
network_acronym_str UNSP
network_name_str Repositório Institucional da UNESP
repository_id_str 2946
spelling The influence of leukocytospermia on the outcomes of assisted reproductive technologyLeukocytospermiaICSIIMSIReactive oxygen speciesDNA damageBackground: It is not well established whether the increased number of leukocytes in the seminal fluid impairs the outcomes of assisted reproductive technology (ART). This investigation analysed the outcomes of the intracytoplasmic sperm injection (ICSI) and intracytoplasmic morphologically selected sperm injection (IMSI) cycles in couples in which the male partner exhibited leukocytospermia.Methods: A total of 100 cycles in 100 couples were included in this study. For the ICSI or IMSI procedures, the patients were divided into two groups according to the presence or absence of leukocytospermia and then matched by (female) age:- ICSI: Group I (n = 25): Leukocytospermia - semen samples with a leukocyte count of greater than or equal to 1 x 10(6)/mL; and Group II (n = 25): Non-leukocytospermia - semen samples with a leukocyte count < 1 x 10(6)/mL.- IMSI: Group I (n = 25): Leukocytospermia; and Group II (n = 25): Non-leukocytospermia.The endpoints included the rates of fertilisation, implantation, clinical pregnancy, miscarriage, ongoing pregnancy and live birth. Student's t-tests, Mann-Whitney tests and Chi-square tests were performed, and P < 0.05 was considered significant.Results: The data from the ICSI groups showed that leukocytospermia did not have a negative influence on the rates of fertilisation (Group I: 57.9+/-30.2%, Group II: 61.9+/-27.7%; P = 0.74), implantation (Group I: 12.3%; Group II: 13.5%; P = 0.93), clinical pregnancy (Group I: 24%; Group II: 24%; P = 1.0), miscarriage ( Group I: 0, Group II: 0), ongoing pregnancy (Group I: 24%; Group II: 24%; P = 1.0), or live births (Group I: 24%; Group II: 24%; P = 1.0). Similarly, the data from the IMSI groups also showed that the leukocytospermia did not have a negative influence on the rates of fertilisation (Group I: 67.6+/-24.6%, Group II: 59.5+/-28.1%; P = 0.36), implantation (Group I: 17.5%; Group II: 16.7%; P = 0.90), clinical pregnancy (Group I: 28%; Group II: 24%; P = 1.0), miscarriage (Group I: 14.3%; Group II: 0; P = 0.33), ongoing pregnancy (Group I: 24%; Group II: 24%; P = 1.0), or live births (Group I: 24%, 6/25; Group II: 24%, 6/25; P = 1.0).Conclusions: The results indicate that the leukocytospermia may not have a negative effect on the outcomes of ICSI or IMSI cycles. Nevertheless, it seems that it is necessary to more precisely determine the effects, if any, of seminal leukocytes on fertilisation and implantation processes. Such efforts will help to establish a more reliable leukocyte threshold, which could eventually demonstrate whether there is a negative influence on the ART procedures.Ctr Human Reprod Prof Franco Jr, Ribeirao Preto, BrazilHosp Perola Byington, Womens Hlth Reference Ctr, São Paulo, BrazilPaulista Ctr Diag Res & Training, Ribeirao Preto, BrazilSão Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, BrazilSão Paulo State Univ UNESP, Botucatu Med Sch, Dept Gynecol & Obstet, Botucatu, SP, BrazilBiomed Central Ltd.Ctr Human Reprod Prof Franco JrHosp Perola ByingtonPaulista Ctr Diag Res & TrainingUniversidade Estadual Paulista (Unesp)Cavagna, MarioOliveira, Joao Batista A. [UNESP]Petersen, Claudia G. [UNESP]Mauri, Ana L.Silva, Liliane F. I. [UNESP]Massaro, Fabiana C.Baruffi, Ricardo L. R.Franco, Jose G. [UNESP]2014-05-20T13:35:39Z2014-05-20T13:35:39Z2012-06-15info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article10application/pdfhttp://dx.doi.org/10.1186/1477-7827-10-44Reproductive Biology and Endocrinology. London: Biomed Central Ltd., v. 10, p. 10, 2012.1477-7827http://hdl.handle.net/11449/1227510.1186/1477-7827-10-44WOS:000308910500001WOS000308910500001.pdfWeb of Sciencereponame:Repositório Institucional da UNESPinstname:Universidade Estadual Paulista (UNESP)instacron:UNESPengReproductive Biology and Endocrinology2.8521,203info:eu-repo/semantics/openAccess2023-10-03T06:04:31Zoai:repositorio.unesp.br:11449/12275Repositório InstitucionalPUBhttp://repositorio.unesp.br/oai/requestopendoar:29462023-10-03T06:04:31Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)false
dc.title.none.fl_str_mv The influence of leukocytospermia on the outcomes of assisted reproductive technology
title The influence of leukocytospermia on the outcomes of assisted reproductive technology
spellingShingle The influence of leukocytospermia on the outcomes of assisted reproductive technology
Cavagna, Mario
Leukocytospermia
ICSI
IMSI
Reactive oxygen species
DNA damage
title_short The influence of leukocytospermia on the outcomes of assisted reproductive technology
title_full The influence of leukocytospermia on the outcomes of assisted reproductive technology
title_fullStr The influence of leukocytospermia on the outcomes of assisted reproductive technology
title_full_unstemmed The influence of leukocytospermia on the outcomes of assisted reproductive technology
title_sort The influence of leukocytospermia on the outcomes of assisted reproductive technology
author Cavagna, Mario
author_facet Cavagna, Mario
Oliveira, Joao Batista A. [UNESP]
Petersen, Claudia G. [UNESP]
Mauri, Ana L.
Silva, Liliane F. I. [UNESP]
Massaro, Fabiana C.
Baruffi, Ricardo L. R.
Franco, Jose G. [UNESP]
author_role author
author2 Oliveira, Joao Batista A. [UNESP]
Petersen, Claudia G. [UNESP]
Mauri, Ana L.
Silva, Liliane F. I. [UNESP]
Massaro, Fabiana C.
Baruffi, Ricardo L. R.
Franco, Jose G. [UNESP]
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Ctr Human Reprod Prof Franco Jr
Hosp Perola Byington
Paulista Ctr Diag Res & Training
Universidade Estadual Paulista (Unesp)
dc.contributor.author.fl_str_mv Cavagna, Mario
Oliveira, Joao Batista A. [UNESP]
Petersen, Claudia G. [UNESP]
Mauri, Ana L.
Silva, Liliane F. I. [UNESP]
Massaro, Fabiana C.
Baruffi, Ricardo L. R.
Franco, Jose G. [UNESP]
dc.subject.por.fl_str_mv Leukocytospermia
ICSI
IMSI
Reactive oxygen species
DNA damage
topic Leukocytospermia
ICSI
IMSI
Reactive oxygen species
DNA damage
description Background: It is not well established whether the increased number of leukocytes in the seminal fluid impairs the outcomes of assisted reproductive technology (ART). This investigation analysed the outcomes of the intracytoplasmic sperm injection (ICSI) and intracytoplasmic morphologically selected sperm injection (IMSI) cycles in couples in which the male partner exhibited leukocytospermia.Methods: A total of 100 cycles in 100 couples were included in this study. For the ICSI or IMSI procedures, the patients were divided into two groups according to the presence or absence of leukocytospermia and then matched by (female) age:- ICSI: Group I (n = 25): Leukocytospermia - semen samples with a leukocyte count of greater than or equal to 1 x 10(6)/mL; and Group II (n = 25): Non-leukocytospermia - semen samples with a leukocyte count < 1 x 10(6)/mL.- IMSI: Group I (n = 25): Leukocytospermia; and Group II (n = 25): Non-leukocytospermia.The endpoints included the rates of fertilisation, implantation, clinical pregnancy, miscarriage, ongoing pregnancy and live birth. Student's t-tests, Mann-Whitney tests and Chi-square tests were performed, and P < 0.05 was considered significant.Results: The data from the ICSI groups showed that leukocytospermia did not have a negative influence on the rates of fertilisation (Group I: 57.9+/-30.2%, Group II: 61.9+/-27.7%; P = 0.74), implantation (Group I: 12.3%; Group II: 13.5%; P = 0.93), clinical pregnancy (Group I: 24%; Group II: 24%; P = 1.0), miscarriage ( Group I: 0, Group II: 0), ongoing pregnancy (Group I: 24%; Group II: 24%; P = 1.0), or live births (Group I: 24%; Group II: 24%; P = 1.0). Similarly, the data from the IMSI groups also showed that the leukocytospermia did not have a negative influence on the rates of fertilisation (Group I: 67.6+/-24.6%, Group II: 59.5+/-28.1%; P = 0.36), implantation (Group I: 17.5%; Group II: 16.7%; P = 0.90), clinical pregnancy (Group I: 28%; Group II: 24%; P = 1.0), miscarriage (Group I: 14.3%; Group II: 0; P = 0.33), ongoing pregnancy (Group I: 24%; Group II: 24%; P = 1.0), or live births (Group I: 24%, 6/25; Group II: 24%, 6/25; P = 1.0).Conclusions: The results indicate that the leukocytospermia may not have a negative effect on the outcomes of ICSI or IMSI cycles. Nevertheless, it seems that it is necessary to more precisely determine the effects, if any, of seminal leukocytes on fertilisation and implantation processes. Such efforts will help to establish a more reliable leukocyte threshold, which could eventually demonstrate whether there is a negative influence on the ART procedures.
publishDate 2012
dc.date.none.fl_str_mv 2012-06-15
2014-05-20T13:35:39Z
2014-05-20T13:35:39Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1186/1477-7827-10-44
Reproductive Biology and Endocrinology. London: Biomed Central Ltd., v. 10, p. 10, 2012.
1477-7827
http://hdl.handle.net/11449/12275
10.1186/1477-7827-10-44
WOS:000308910500001
WOS000308910500001.pdf
url http://dx.doi.org/10.1186/1477-7827-10-44
http://hdl.handle.net/11449/12275
identifier_str_mv Reproductive Biology and Endocrinology. London: Biomed Central Ltd., v. 10, p. 10, 2012.
1477-7827
10.1186/1477-7827-10-44
WOS:000308910500001
WOS000308910500001.pdf
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Reproductive Biology and Endocrinology
2.852
1,203
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 10
application/pdf
dc.publisher.none.fl_str_mv Biomed Central Ltd.
publisher.none.fl_str_mv Biomed Central Ltd.
dc.source.none.fl_str_mv Web of Science
reponame:Repositório Institucional da UNESP
instname:Universidade Estadual Paulista (UNESP)
instacron:UNESP
instname_str Universidade Estadual Paulista (UNESP)
instacron_str UNESP
institution UNESP
reponame_str Repositório Institucional da UNESP
collection Repositório Institucional da UNESP
repository.name.fl_str_mv Repositório Institucional da UNESP - Universidade Estadual Paulista (UNESP)
repository.mail.fl_str_mv
_version_ 1797789277011050496